PUBLIC COMMENT
CSQ has been hard at work and is excited to release our EU-GMP Addendum for public comment.
The CSQ EU-GMP Addendum - Public Comment Package contains:
- CSQ EU-GMP Addendum - outlines the audit requirements for the CSQ EU-GMP Addendum
- CSQ Public Comment Form - used to document and submit your suggested changes and feedback
- CSQ2.0 Certification Program Requirements - outlines the requirements for getting CSQ Certified
- CSQ2.0 Full Level 3 Audit Requirements Check List - breaks down the baseline audit requirements of the CSQ Standards that the CSQ EU-GMP Addendum builds upon
Comments related to the CSQ EU-GMP Addendum are welcome during this public comment period.
During your review, please:
- Identify terms and references that need to be harmonized.
- Identify terms that need definition.
- Identify references that need to be added to the appendix.
- Ask any clarifying questions and point out any contradictory requirements or conflicts with regulatory compliance.
- Complete your review and send your markups no later than May 31st, 2026.
At any time if you have questions, please do not hesitate to reach out to us – info@csqcertification.com
We want to make our program as effective as possible and rely on you all to provide that sounding board to ensure what’s on paper can easily and efficiently be implemented in reality.
Feel free to share this document package with your networks. The more feedback we can get, the better.
PUBLIC COMMENT
Before updates to the CSQ Certification Program are made, a public comment period is held to gather feedback on the revisions. Public comment periods are conducted for a minimum of thirty (30) days. Resources for making public comments on the CSQ Certification Program and associated documentation are made available during the public comment period. Announcements of public comment periods will be published on the CSQ LinkedIn Page and various other outlets. During active public comment periods, resources can be found on this page along with a description of the documents under review.